Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation with recombinant erythropoietin.
Heyll
A
A
Aul
C
C
Runde
V
V
Arning
M
M
Schneider
W
W
Wernet
P
P
D000017:ABO Blood-Group System; D000328:Adult; D001787:Blood Group Incompatibility / Q000150:complications*; D016026:Bone Marrow Transplantation; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011994:Recombinant Proteins / Q000627:therapeutic use; D012010:Red-Cell Aplasia, Pure / Q000188:drug therapy* / Q000209:etiology
D000017:ABO Blood-Group System; D011994:Recombinant Proteins; D004921:Erythropoietin